Preneoplastic mammary tumor markers: Cripto and amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice

Amphiregulin (Ar) and Cripto (Cr) are autocrine growth factors for mammary cells and both have been observed to exhibit high expression in human mammary tumors, in contrast with adjacent tissues. To investigate whether Ar and Cr play roles in the progression of mammary cell proliferation to unregulated growth and tumor formation, the levels of expression were examined in transgenic mice (TGM) that over‐express several different oncogenes: MMTV‐Polyoma virus middle T antigen (MMTV‐PyMT), MMTV‐c‐ErbB2 (c‐neu, HER2) and MT‐hTGFα. These transgenic mice all produce mammary tumors but with different rates of progression. The levels of Ar were induced up to 10‐fold in association with hyperplasia in 2 of the TGM. Cr overexpression was consistently observed in hyperplastic mammary glands in all the animal models, decreasing in overt tumors in 2 of the TGM models. In MMTV‐PyMT mammary glands, the levels of Cr expression rose 7‐ to 10‐fold in hyperplastic tissue and 25‐fold the levels in tumors compared to age‐matched transgene negative mice. Ar and especially Cr thus should have potential value as markers of preneoplastic change in mammary tissue. Int. J. Cancer 81:588–591, 1999. © 1999 Wiley‐Liss, Inc.

[1]  E. Adamson,et al.  Cripto: roles in mammary cell growth, survival, differentiation and transformation , 1998, Cell Death and Differentiation.

[2]  R. Dickson,et al.  Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[3]  D. Salomon,et al.  Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice , 1996, Molecular carcinogenesis.

[4]  R. Sharp,et al.  Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. , 1995, The American journal of pathology.

[5]  D. Salomon,et al.  Detection and location of amphiregulin and Cripto‐1 expression in the developing postnatal mouse mammary gland , 1995, Molecular reproduction and development.

[6]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[7]  R. Coffey,et al.  Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. , 1994, The Journal of biological chemistry.

[8]  N. Normanno,et al.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, The Journal of biological chemistry.

[9]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[10]  N. Normanno,et al.  Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Shoyab,et al.  Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. , 1993, The Journal of biological chemistry.

[12]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Salomon,et al.  Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon , 1992, The Journal of cell biology.

[14]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[15]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[16]  G. Merlino,et al.  TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.

[17]  C R King,et al.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.

[18]  R. Weinberg,et al.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen , 1984, Nature.

[19]  S. Cohen,et al.  Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver. , 1982, Proceedings of the National Academy of Sciences of the United States of America.